v3.26.1
ADDITIONAL PAID-IN CAPITAL
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
ADDITIONAL PAID-IN CAPITAL [Text Block]

10. ADDITIONAL PAID-IN CAPITAL

a) Stock options

The Company is authorized to grant stock options to directors, employees, and consultants pursuant to its stock option plan for up to 20% of the Company's issued and outstanding common shares. Stock options are granted at the discretion of the Board of Directors and may vest immediately or upon the achievement of specified performance milestones.

The exercise price of each option cannot be lower than the closing market share price of the Company's common shares on the trading day preceding the grant. Most options are granted for a term of five years and invested immediately, except for those subject to performance milestones.

During the six months ended June 30, 2025, the Company granted the following stock options:

  • 7,500,000 performance options with an exercise price of $0.08, expiring on April 4, 2030, and vest as follows:
    • 3,750,000 vest upon either (a) the market capitalization of the Company's common shares reaches $100,000 for any 30 consecutive trading days or (b) the Company closing a liquidity event having a fair market value of no less than $100,000 (met);
    • 3,750,000 vest upon either (a) the market capitalization of the Company's common shares reaches $200,000 for any 30 consecutive trading days or (b) the Company closing a liquidity event having a fair market value of no less than $200,000;

The performance options were valued using a Monte Carlo simulation model with the following inputs:

  April 4, 2025
Risk-free interest rate 2.52%
Expected volatility 125%
Dividend yield 0%
Market Cap $100M/$200M
Exercise Price $0.08
Simulation Paths 10,000

The following table summarizes the continuity of the number of stock options issued and outstanding:

    June 30, 2026     December 31, 2025  
    Number
of options
    Weighted average
exercise price
(CAD)
    Number
of options
    Weighted average
exercise price
(CAD)
 
Outstanding, beginning of period   88,540,965     0.10     63,735,248   $ 0.09  
Granted   -     -     29,000,000     0.05  
Exercised   (4,950,000 )   (0.08 )   (2,223,635 )   (0.08 )
Expired   (1,750,000 )   (0.25 )   (1,970,648 )   (0.08 )
Outstanding, ending of period   81,840,965     0.10     88,540,965     0.10  
Exercisable, ending of period   78,090,965     0.10     81,040,965     0.10  

As of June 30, 2026, all stock options were fully vested except for 3,750,000 granted on April 5, 2025.

As of June 30, 2026, the number of stock options outstanding and exercisable were:

Expiry date   Exercise price
(CAD)
    Number of
options
outstanding
    Remaining
contractual life
in years
    Number of
options
exercisable
 
June 18, 2026*   0.245     800,000     -     800,000  
October 21, 2026   0.09     900,000     0.31     900,000  
May 25, 2027   0.085     2,000,000     0.90     2,000,000  
March 2, 2028   0.095     350,000     1.67     350,000  
July 21, 2028   0.08     15,715,965     2.06     15,715,965  
March 1, 2029   0.07     12,865,000     2.67     12,865,000  
July 26, 2029   0.08     7,500,000     3.07     7,500,000  
December 10, 2029   0.085     12,710,000     3.45     12,710,000  
April 4, 2030   USD 0.08     7,500,000     3.76     3,750,000  
September 5, 2030   0.12     20,000,000     4.19     20,000,000  
September 8, 2030   0.135     1,500,000     4.19     1,500,000  
Balance, June 30, 2026   81,840,965           78,090,965  

*Under the Company's Stock Option Plan, the expiry date of certain stock options has been extended beyond June 18, 2026, as the original expiry fell within a corporate trading blackout period.

As of December 31, 2025, the number of stock options outstanding and exercisable were:

Expiry date   Exercise price
(CAD)
    Number of
options
outstanding
    Remaining
contractual life
in years
    Number of
options
exercisable
 
June 18, 2026   0.245     2,550,000     0.46     2,550,000  
October 21, 2026   0.09     900,000     0.81     900,000  
May 25, 2027   0.085     2,000,000     1.40     2,000,000  
March 2, 2028   0.095     350,000     2.17     350,000  
July 21, 2028   0.08     16,215,965     2.56     16,215,965  
March 1, 2029   0.07     12,865,000     3.17     12,865,000  
July 26, 2029   0.08     7,500,000     3.57     7,500,000  
December 10, 2029   0.085     17,160,000     3.95     17,160,000  
April 4, 2030   USD 0.08     7,500,000     4.26     -  
September 5, 2030   0.12     20,000,000     4.68     20,000,000  
September 8, 2030   0.135     1,500,000     4.69     1,500,000  
Balance, December 31, 2025         88,540,965           81,040,965  

During the six months ended June 30, 2026, the Company recognized shared-based compensation expense of $88 (2025 - $1,257) related to the vesting of options. Share-based compensation expense is recorded over the vesting period of the respective awards.

b) Share purchase warrants

The following table summarizes the continuity of the number of warrants issued and outstanding:

    June 30, 2026     December 31, 2025  
    Number
of warrants
    Weighted
average
exercise price
    Number
of warrants
    Weighted
average
exercise price
 
Outstanding, beginning of period   122,759,564   $ 0.06     110,477,171   $ 0.06  
Warrants issued   -     -     27,979,275     0.10  
Warrants exercised   (12,661,718 )   (0.07 )   -     -  
Warrants expired   -     -     (15,696,882 )   (0.06 )
Outstanding, end of period   110,097,846   $ 0.070     122,759,564   $ 0.06  

The following table summarizes warrants outstanding as of June 30, 2026 and December 31, 2025:

Grant Date   Exercise
Price ($)
    Expiry Date     June 30, 2026     December 31, 2025  
March 8, 2024   0.056     March 8, 2029     25,536,568     27,917,520  
September 19, 2024   0.056     September 19, 2029     40,978,549     41,707,215  
November 8, 2024   0.06     November 8, 2029     20,266,666     25,155,554  
November 6, 2025   0.0965     November 6, 2030     23,316,063     27,979,275  
                110,097,846     122,759,564